Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Innate Pharma SA
F:IDD
Innate Pharma SA
F:IDD
Price:
1.306
EUR
2.51%
Market Closed
Market Cap:
€105.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Innate Pharma SA
F:IDD
|
FR |
|
PTT Oil and Retail Business PCL
SET:OR
|
TH |
|
I
|
Innate Pharma SA
OTC:IPHYF
|
FR |
|
Life360 Inc
F:L36
|
US |
|
P
|
Petchsrivichai Enterprise PCL
SET:PCE
|
TH |
|
I
|
Ipsos SA
XMUN:IPZ
|
FR |
|
U
|
Union Plastic PCL
SET:UP
|
TH |
|
S
|
STC Concrete Product Public Company Limited
SET:STC
|
TH |
|
T
|
Thai Packaging & Printing PCL
SET:TPP
|
TH |
|
Banca IFIS SpA
MIL:IF
|
IT |
|
U
|
Ucb SA
F:UNC
|
BE |
|
M
|
Mark2 Corporation Investment SE
PSE:M2C
|
CZ |
|
B
|
B-52 Capital PCL
SET:B52
|
TH |
|
U
|
United Paper PCL
SET:UTP
|
TH |
|
PLC SpA
MIL:PLC
|
IT |
|
P
|
Peoples Garment PCL
SET:PG
|
TH |
|
V
|
Victory Square Technologies Inc
F:6F6
|
CA |
|
B
|
Boutique Corporation PCL
SET:BC
|
TH |
|
OceanFirst Financial Corp
NASDAQ:OCFC
|
US |
|
Scandinavian Investment Group A/S
F:2D2
|
DK |
|
S
|
Sanko Diecasting Thailand PCL
SET:SANKO
|
TH |
|
S
|
Stone One PCL
SET:STX
|
TH |
|
Searchlight Resources Inc
F:2CC
|
CA |
|
E
|
Earthwise Minerals Corp
CNSX:WISE
|
CA |
Wall St Price Targets
IDD Price Forecast
Based on 6 analysts
Based on 6 analysts
+410% Upside
from
€1.306
today
Innate Pharma SA (IDD)’s 12-month stock price forecast through October 2027 has a consensus target of €6.664, implying 410% upside. The forecast is based on price targets from 6 Wall Street analysts.
IDD Analyst Rating
No ratings yet
No ratings yet
Innate Pharma SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IDD's stock price target?
Price Target
6.664
EUR
6.664
EUR
According to Wall Street analysts, the average 1-year price target for IDD is 6.664 EUR with a low forecast of 5.865 EUR and a high forecast of 8.711 EUR.
What is the Revenue forecast for Innate Pharma SA?
Projected CAGR
92%
92%
Over the last 13 years, the compound annual growth rate for Revenue has been -10%. The projected CAGR for the next 7 years is 92%.
What is the Gross Profit forecast for Innate Pharma SA?
Projected CAGR
994%
994%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -22%. The projected CAGR for the next 3 years is 994%.